logo

For the Inventor, By the Inventor

Needham, MA, United States of America

Andre Rosowsky

This inventor holds 10 USPTO granted patents. Top assignees: Dana-Farber-Cancer Institute Inc., Ash Stevens, Inc., Other. Active years: 1984-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andre Rosowsky. Retrieved from https://idiyas.com/inventor/andre-rosowsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 60.0

Average Co-Inventor Count = 1.4

ph-index = 4

Forward Citations = 32(Granted Patents)


Company Filing History:

goldMedal9 out of 1,268 
 
Dana-Farber-Cancer Institute Inc.
 patents
silverMedal1 out of 8 
 
Ash Stevens, Inc.
 patents
bronzeMedal1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1984-2007

Loading Chart...
10 patents (USPTO):Explore Patents
1. 7256197 - Methods for synthesis of diarylmethanes (2007-08-14),
2. 7119095 - Pharmaceutically active compounds and methods of use thereof (2006-10-10),
3. 7056911 - Dibenz[B,F]azepine compounds, pharmaceutical compositions comprising same and methods of use thereof (2006-06-06),
4. 6989386 - Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same (2006-01-24),
5. 6686462 - Antiviral compounds and methods of administration (2004-02-03),
6. 5234925 - 2-aza-2-desamino analogues of 5,8-dideazafolic acid (1993-08-10),
7. 5132414 - Dideoxynucleoside-5'-phosphonoformic acid compounds (1992-07-21),
8. 4956461 - Desamino-aminopterin and -methotrexate (1990-09-11),
9. 4767761 - Ornithine derivatives and their use as methotrexate-resistant cell (1988-08-30),
10. 4490529 - Cysteic acid and homocysteic acid analogues of methotrexate and (1984-12-25),

Title: Andre Rosowsky: Innovator in Pharmaceutical Chemistry

Introduction

Andre Rosowsky is a notable inventor based in Needham, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work primarily focuses on the development of dihydrofolate reductase inhibitors, which are crucial in the treatment of various diseases.

Latest Patents

Among his latest patents, Rosowsky has developed methods for the synthesis of diarylmethanes. This invention relates to dihydrofolate reductase inhibitors that feature an aromatic group and a heteroaromatic group linked by a methylene group. Additionally, he has created methods of preparation for these inhibitors, which include metal-mediated cross-coupling of an aromatic halide or heteroaromatic halide with an organozinc reagent. Furthermore, his patents encompass methods of treatment and pharmaceutical compositions that utilize or comprise these dihydrofolate reductase inhibitors.

Career Highlights

Throughout his career, Andre Rosowsky has worked with prestigious organizations, including the Dana-Farber Cancer Institute Inc. His innovative research has significantly impacted the pharmaceutical industry, particularly in the development of effective treatments.

Collaborations

Rosowsky has collaborated with esteemed colleagues, including Karl Y. Hostetler and James R. Beadle. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Andre Rosowsky's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a leading inventor in the field. His work continues to influence the development of critical treatments, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…